Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. hiv disease
Show results for
Products
Services
Training

Companies

News
Articles
Downloads

Refine by
Date

  • Older

Hiv Disease Articles & Analysis

27 news found

Advanced Lung Function Measurement In A Novel HIV/Tuberculosis Co-Infection Mouse Model

Advanced Lung Function Measurement In A Novel HIV/Tuberculosis Co-Infection Mouse Model

Tuberculosis (TB) and Human Immunodeficiency Virus (HIV) are major global health threats. Their interaction worsens disease severity, as HIV reduces CD4+ T cells, making individuals more vulnerable to TB. Despite progress, an effective animal model that mimics human immune response during HIV/TB co-infection has been lacking, ...

BySCIREQ - an emka TECHNOLOGIES Company


Microneedle Market Projected to Reach $1.3 Billion by 2028, Reveals Latest BCC Research Study

Microneedle Market Projected to Reach $1.3 Billion by 2028, Reveals Latest BCC Research Study

Boston: Microneedle technology, driven by high demand in dermatologic procedures and its versatile applications in drug delivery, vaccine administration, and disease diagnostics, faces challenges in its complex manufacturing process. Ongoing research and numerous products in development make this market dynamic for newcomers entering the field. “According to the latest BCC Research study, ...

ByBCC Research


CD Bioparticles Launches mRNA Transfection Reagents for Research Applications

CD Bioparticles Launches mRNA Transfection Reagents for Research Applications

In addition, these new reagents can be applied in various fields, such as mRNA-base vaccine therapy for malignant tumors, protein replacement therapy, and gene editing using mRNA recombination technology. mRNA vaccines protect against infectious diseases like influenza, rabies, HIV and Zika virus infections. This mRNA Transfection Reagent (Catalog: WHM-OB24, unit ...

ByCD Bioparticles


BOC Sciences: Peptides Open New Path toward Osteoporosis Treatment

BOC Sciences: Peptides Open New Path toward Osteoporosis Treatment

About With a long-term experience in peptide manufacturing, synthesis, and analysis, BOC Sciences has gained fame in providing a series of peptides for diverse therapeutic areas, for instance, research on osteoporosis, cancer, cardiovascular disease, diabetes, and HIV. ...

ByBOC Sciences


NanoPin Technologies Founder`s Study Demonstrates Greater Accuracy in Detecting TB in Infants

NanoPin Technologies Founder`s Study Demonstrates Greater Accuracy in Detecting TB in Infants

We believe that there should be a strong focus on infectious disease research and diagnostic technologies that serve young children due to the challenges that are unique to this group.” About Tuberculosis Tuberculosis, an infectious bacterial disease, is a leading cause of death worldwide, despite being preventable and often curable. ...

ByNanoPin Technologies Inc.


BOC Sciences Outlines Its Contribution of Peptides to Cardiovascular Research   

BOC Sciences Outlines Its Contribution of Peptides to Cardiovascular Research  

February is set as American Heart Month since heart disease is the number one cause of death for most groups, affecting all ages, genders, and races. More than 600,000 Americans die from heart disease every year. The striking fact drives a great deal of cardiovascular research worldwide, among which peptide development is brought into focus owing to its certain ...

ByBOC Sciences


BOC Sciences August Promotion: Compound Docking Solutions for Drug Discovery

BOC Sciences August Promotion: Compound Docking Solutions for Drug Discovery

"We have witnessed many successful cases of compound docking applications in drugs for the treatment of HIV, cancers, and other prevalent diseases. The technical details refer to docking algorithms, Cresset software, other relevant computational methods, etc., which in combination make up our comprehensive service package," commented a senior scientist of BOC ...

ByBOC Sciences


Peptides for Diabetes Research—a Special Offer of BOC Sciences

Peptides for Diabetes Research—a Special Offer of BOC Sciences

Presently, its peptide products can be applied in the treatment of multiple diseases (diabetes, cancer, Alzheimer's disease, HIV, HPV, etc.) and have very good curative effects. ...

ByBOC Sciences


MOBILion and International Research Team are Awarded Grant from The Michael J. Fox Foundation and the Shake it Up Australia Foundation to Resolve Biomarkers for Parkinson’s Disease

MOBILion and International Research Team are Awarded Grant from The Michael J. Fox Foundation and the Shake it Up Australia Foundation to Resolve Biomarkers for Parkinson’s Disease

MOBILion Systems, Inc., a pioneer in fast, efficient, high-resolution instrumentation for biomarker discovery, diagnostics and therapeutic development, is collaborating with an international research team to identify alterations in the metabolism of selective glycosphingolipids in specific brain regions that contribute to the early onset and progression of Parkinson’s ...

ByMOBILion Systems, Inc.


Frontier Biotechnologies` First Long-acting Injectable (Aikening(R), in a Two Drug Regimen for HIV, Proves Safe and Efficacious for Patients

Frontier Biotechnologies` First Long-acting Injectable (Aikening(R), in a Two Drug Regimen for HIV, Proves Safe and Efficacious for Patients

Further, approximately 25% of patients had CD4 cell count of less than 100, indicating advanced HIV disease with highly compromised immunity, who were at high risk of opportunistic diseases and death. ...

ByFrontier Biotechnologies Inc.


Creative Enzymes Launched Tn5 Transposase for Genetic Experimentation

Creative Enzymes Launched Tn5 Transposase for Genetic Experimentation

• The study of Tnp Tn5 is important because of its similarity to HIV-1 and other retroviral diseases. • By studying Tn5, more about other transposases and their activities can also be discovered. ...

ByCreative Enzymes


NanoPin Technologies Announce a Strategic Collaboration with Shanghai Reigncom Biotechnology to Bring Novel Infectious Disease Diagnostic Products to the China Market

NanoPin Technologies Announce a Strategic Collaboration with Shanghai Reigncom Biotechnology to Bring Novel Infectious Disease Diagnostic Products to the China Market

This collaboration will promote the development of mass spectrometry-based infectious disease blood detection technologies throughout China, with initial applications addressing the global tuberculosis (TB) epidemic. ...

ByNanoPin Technologies Inc.


BIO CEO Defends Dr. Fauci, Says Criticisms `Undermine Our Response to this Pandemic`

BIO CEO Defends Dr. Fauci, Says Criticisms `Undermine Our Response to this Pandemic`

We have benefited from his medical and scientific guidance for over 30 years, ever since his appointment by President Reagan. He has guided the world through HIV, Ebola, and SARS. We need his firsthand historical and scientific knowledge now more than ever. ...

ByBiotechnology Industry Organization (BIO)


Velano raises $15M to go beyond non-invasive blood tests

Velano raises $15M to go beyond non-invasive blood tests

So, it was ‘let’s not stick patients because it’s a really sub-optimal experience,’ but also now it’s, ‘let’s aim to provide a safer experience for practitioners so that they don’t have to wield a needle to get blood out of a patient that, perhaps, has a blood borne illness, communicable disease, like HIV or ...

ByVelano Vascular


Lauren Sciences LLC research team at Ben-Gurion University awarded grant from The ALS Association to develop V-Smart Therapeutic for ALS

Lauren Sciences LLC research team at Ben-Gurion University awarded grant from The ALS Association to develop V-Smart Therapeutic for ALS

About Lauren Sciences LLC Lauren Sciences is developing a robust pipeline of transformative V-Smart™ therapeutics for CNS diseases, such as Parkinson's disease, neuro-HIV, ALS and more. Lauren Sciences has been awarded grants for the development of V-Smart™ therapeutics from foundations such as The Michael J. ...

ByLauren Sciences LLC


Lauren Sciences LLC research team at Ben-Gurion University successfully completes Campbell Foundation 1-year grant to develop V-Smart therapeutic for neuro-HIV

Lauren Sciences LLC research team at Ben-Gurion University successfully completes Campbell Foundation 1-year grant to develop V-Smart therapeutic for neuro-HIV

The persistence of HIV in the CNS (called “neuro-HIV”) is a major contributor to HIV-associated neurological impairment and is perceived to be a major cause of inability to completely control systemic HIV despite long-term highly active anti-retroviral treatment (HAART). ...

ByLauren Sciences LLC


Lauren Sciences independently recognized as a Technology Innovator in Drug Delivery with its V-Smart Platform, and selected as a Featured Company, in new report by MCD Group

Lauren Sciences independently recognized as a Technology Innovator in Drug Delivery with its V-Smart Platform, and selected as a Featured Company, in new report by MCD Group

The MCD Group report includes an in-depth profile of Lauren Sciences, providing a scientific description of the V-Smart™ technology and detailed information on its V-Smart™ therapeutic programs in central nervous system (CNS) diseases such as Parkinson's disease, neuro-HIV and brain cancer. "The inclusion of Lauren Sciences in the ...

ByLauren Sciences LLC


Powering the Fight Against Malaria & Aids

Powering the Fight Against Malaria & Aids

The new facility comes at a crucial time in Africa’s fight against malaria and other infectious diseases. According to the WHO about half the world’s population is at risk of malaria, HIV/AIDS and infectious diseases. ...

ByClarke Energy


Findings from Cornell University College of Medicine in HIV/AIDS Reported

Findings from Cornell University College of Medicine in HIV/AIDS Reported

Investigators discuss in "a(1)Proteinase Inhibitor Regulates CD4 Lymphocyte Levels and Is Rate Limiting in HIV-1 Disease" new findings in HIV/AIDS. According to the authors of recent research from New York City, New York, "The regulation of adult stem cell migration through human hematopoietic tissue involves the chemokine CXCL12 (SDF-1) and its ...

ByALPHA-1 BIOLOGICS LLC


Biomed Analysis: Sustainability goals too light on health

Biomed Analysis: Sustainability goals too light on health

Several goals were health-focused — for example, MDG 4 aims to reduce child mortality, MDG 5 to improve maternal health, and MDG 6 to combat HIV/AIDS, malaria and other infectious diseases. But they also emphasised social issues that affect health, such as achieving universal primary education (MDG 2), eradicating extreme poverty and hunger (MDG 1), and ...

BySciDev.Net

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical Equipment & Supplies
  • Medical Software
  • Medical Training Courses
  • Medical Industry Services
  • Medical Product Applications

Latest

  • Medical Industry News
  • Medical Industry Events

Publications

  • Medical Industry Articles & Case Studies
  • Medical Industry Books and Publications
  • Medical Industry Journals and Magazines
  • Medical Industry Downloads
  • Medical Industry Videos

Companies

  • Medical Industry Suppliers & Manufacturers

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT